Form 4: Dentsply Sirona Executive Brian T. Gladden Reports Acquisition of Stock Dividends
SEC Form 4 Filing
Brian T. Gladden, an executive at Dentsply Sirona, reported the acquisition of stock dividends in the form of additional restricted stock units (RSUs).
Summary
- On April 12, 2024, Brian T. Gladden, an executive at Dentsply Sirona Inc. [XRAY], acquired 28.616 shares of common stock through dividends on restricted stock units (RSUs).
- These dividends were awarded in the form of additional RSUs and are subject to the same vesting terms as the underlying awards.
- Following the transaction, Gladden beneficially owns 5,964.616 shares of Dentsply Sirona common stock.
- The RSUs convert to common stock on a 1:1 basis.
- The report was filed on April 15, 2024, by Dane Baumgardner, Attorney-In-Fact for Brian T. Gladden.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting an insider transaction, which is neutral in sentiment.
Positives
- The acquisition of additional shares through dividends increases Brian T. Gladden's stake in Dentsply Sirona.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company executives.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine acquisition of shares through dividends.
Key Dates
| Date | Description |
|---|---|
| 04/12/2024 | Date of transaction: Acquisition of common stock through dividends on RSUs. |
| 04/15/2024 | Date of filing: Form 4 filed by Dane Baumgardner, Attorney-In-Fact for Brian T. Gladden. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.